Related Experiment Videos
Dietary fat and advanced prostate cancer
1Département de Médecine Sociale et Préventive, Centre de Recherche en Cancérologie de l'Université Laval, Quebec City, Quebec, Canada.
The Journal of Urology
|March 21, 1998
Summary
High saturated fat intake is linked to advanced prostate cancer progression. Dietary fat modification may help prevent prostate cancer advancement, warranting further research.
Area of Science:
- Oncology
- Nutritional Science
- Epidemiology
Background:
- Prostate cancer is a significant health concern.
- Dietary factors, especially fat intake, are hypothesized to influence prostate cancer development and progression.
- Understanding these dietary links is crucial for prevention and management strategies.
Purpose of the Study:
- To identify specific dietary factors, with a focus on fat intake, associated with advanced prostate cancer.
- To investigate the relationship between various types of dietary fat and the progression of prostate cancer.
Main Methods:
- A case series analysis was conducted on prostate cancer patients aged 45 and older.
- Dietary intake was assessed using a diet history questionnaire administered to 384 patients.
- Logistic regression analysis, adjusted for relevant covariates, was employed to determine associations between dietary patterns and advanced prostate cancer.
Main Results:
- A statistically significant association was found between higher saturated fat consumption and advanced prostate cancer (Odds Ratio 2.15).
- Proportional increases in advanced prostate cancer risk correlated significantly with saturated fat intake.
- Trends suggested inverse associations with polyunsaturated and linoleic acid intake, and positive trends for animal fat, while vegetable fat showed a negative trend.
Conclusions:
- The study indicates a potential link between saturated fat consumption and prostate cancer progression.
- Further cohort studies are recommended to confirm these findings.
- Dietary fat modification could be a viable intervention for preventing prostate cancer progression.